Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: March 2008
-
By Donald Zuhn — Last Thursday, Rep. Anna Eshoo (D-CA; at right) introduced a new biologics bill in the House. The bill (H.R. 5629), which would amend Section 351 of the Public Health Service Act to create a regulatory pathway for biosimilars, has been referred to the Committee on Energy and Commerce and…
-
By Kevin E. Noonan — Senator Leahy (at right), reportedly determined to bring S. 1145, the Senate’s patent "reform" bill to the Senate floor for a vote after the spring recess, on Friday released a number of proposed amendments to the bill. Rather than evincing an appreciation of the seriousness of the opposition…
-
By Donald Zuhn — In 2007, patent reform and biologics legislation became front burner issues. Not surprisingly, this did not escape the notice of many biotech and pharmaceutical companies, and for the past few months we have been paying close attention to reports concerning the lobbying efforts of such companies. We have already…
-
By Donald Zuhn — The U.S. Patent and Trademark Office announced today that it will be changing its procedure for handling requests from a practitioner of record to withdraw from representation. The Office also clarified its procedure for handling a request to withdraw from representation made by a practitioner who is not of…
-
Patent Docs Readers: Normally, we do not address the online tools that make it possible to bring Patent Docs to a browser, RSS reader, or e-mail client near you. However, because we have become aware of some issues regarding the delivery (or lack thereof) of our e-mail newsletter, we would like to make an exception…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Cellectis SA v. Precision BioSciences, Inc.5:08-cv-00119; filed March 13, 2008 in the Eastern District of North Carolina Infringement of U.S. Patent Nos.…
-
March 17, 2008 – Recent Decisions: How They Affect Your Corporate IP Practice (Intellectual Property Owners Association) – Arlington, VA March 30-April 1, 2008 – Advanced Courses (Patent Resources Group) – Bonita Springs, FL March 31-April 1, 2008 – Document Management, E-Discovery, and Litigation Readiness (American Conference Institute) – New York, NY April 1-2, 2008…
-
By Christopher P. Singer — Ocean Tomo will be holding its Live IP auction this spring at the Ritz-Carlton in San Francisco on April 1-2, 2008. The two day program is divided into two separate tracks, with one track titled "Leveraging IP for Investors" and the other titled "Corporate IP Strategies." The scheduled…
-
By Kevin E. Noonan — Harry Manbeck, name partner of the Rothwell, Figg, Ernst and Manbeck firm and former Commissioner of the Patent and Trademark Office (1990-1992) has written a letter to Senators Leahy (D-VT) and Specter (R-PA), chairman and ranking member of the Judiciary Committee. The letter concerns provisions of S. 1145,…
-
By Donald Zuhn — Earlier this month, we reported on the appearance of Robert Budens, the President of the Patent Office Professional Association (POPA) at an oversight hearing on the USPTO held by the House Subcommittee on Courts, the Internet, and Intellectual Property in late February. We also reported on appearances by Jon…
Patent Docs 